Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 84.91 |
| Open | 85.60 |
| Bid | 86.12 x 200 |
| Ask | 86.75 x 100 |
| Day's Range | 84.68 - 86.65 |
| 52 Week Range | 49.24 - 94.57 |
| Volume | |
| Avg. Volume | 189,666 |
| Market Cap | 1.552B |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | 16.15 |
| EPS (TTM) | 5.35 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jul 02, 2010 |
| 1y Target Est | 116.80 |
Business WireLigand to Participate in Upcoming Investor Conferences
JUPITER, Fla., May 23, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor conferences:
ZacksAstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
ZacksDyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
© 2024 Yahoo. All rights reserved.